secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2026-08-14T20:10:43+00:00
Accession:  0001493152-26-038356
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

FOXO majority stockholder approves reverse stock split for potential Nasdaq/NYSE American uplisting
--------------------------------------------------------------------------------

- On Aug 13, 2026, Rennova Health (controlled by CEO) approved reverse split amendment via written consent.
- Ratio range 1:50 to 1:1,000; exact ratio set by board solely to facilitate uplisting to Nasdaq or NYSE American.
- Record date Aug 13, 2026; majority stockholder holds ~99.12% of voting rights.
- Reverse split effective no earlier than 20 days after mailing definitive Schedule 14C; FINRA notice required.
- Preliminary Schedule 14C filed Aug 14, 2026; board authorized split only for uplisting application.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315226038356/0001493152-26-038356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315226038356/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer